Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients

Transplant Proc. 1996 Dec;28(6):3485-7.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Azathioprine / therapeutic use
  • Bone Density / drug effects*
  • Calcitriol / therapeutic use*
  • Calcium / blood
  • Calcium Carbonate / therapeutic use*
  • Cyclosporine / therapeutic use
  • Female
  • Glucocorticoids / adverse effects*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation* / physiology
  • Male
  • Middle Aged
  • Osteoporosis / chemically induced
  • Osteoporosis / prevention & control*
  • Parathyroid Hormone / blood
  • Phosphates / blood
  • Postoperative Complications*
  • Prednisone / adverse effects*

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Parathyroid Hormone
  • Phosphates
  • Cyclosporine
  • Calcitriol
  • Calcium Carbonate
  • Azathioprine
  • Calcium
  • Prednisone